Literature DB >> 12707224

Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosis.

Guido Finazzi, Marco Ruggeri, Francesco Rodeghiero, Tiziano Barbui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12707224     DOI： 10.1182/blood-2003-01-0135

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Anagrelide: a review of its use in the management of essential thrombocythaemia.

Authors:  Antona J Wagstaff; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Long-term follow-up of essential thrombocythemia in young adults: treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients.

Authors:  Francesca Palandri; Nicola Polverelli; Emanuela Ottaviani; Fausto Castagnetti; Michele Baccarani; Nicola Vianelli
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

3.  Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

Authors:  Tiziano Barbui; Giovanni Barosi; Gunnar Birgegard; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

Review 4.  Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.

Authors:  David Dingli; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

Review 5.  Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?

Authors:  Aziz Nazha; Aaron T Gerds
Journal:  Oncologist       Date:  2016-03-14

6.  An ulceronecrotic foot lesion in a patient with essential thrombocythemia: successful treatment with hydroxyurea.

Authors:  Tokue Kato; Seiji Kawana
Journal:  Case Rep Dermatol       Date:  2012-01-18

7.  Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.

Authors:  May Levin; Michal Stark; Bluma Berman; Yehuda G Assaraf
Journal:  Cell Death Dis       Date:  2019-05-17       Impact factor: 8.469

Review 8.  Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Leukemia       Date:  2021-09-03       Impact factor: 11.528

Review 9.  Essential Thrombocythemia in Children and Adolescents.

Authors:  Maria Caterina Putti; Irene Bertozzi; Maria Luigia Randi
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

10.  Philadelphia-negative chronic myeloproliferative neoplasms.

Authors:  Rosane Isabel Bittencourt; Jose Vassallo; Maria de Lourdes Lopes Ferrari Chauffaille; Sandra Guerra Xavier; Katia Borgia Pagnano; Ana Clara Kneese Nascimento; Carmino Antonio De Souza; Carlos Sergio Chiattone
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.